• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and hu

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2021 Oct 19;118(42):e2106480118.
doi: 10.1073/pnas.2106480118.
Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2


Chen Chen[SUP] 1 [/SUP], Veda Sheersh Boorla[SUP] 1 [/SUP], Deepro Banerjee[SUP] 2 [/SUP], Ratul Chowdhury[SUP] 1 [/SUP], Victoria S Cavener[SUP] 3 [/SUP], Ruth H Nissly[SUP] 4 [/SUP], Abhinay Gontu[SUP] 3 [/SUP], Nina R Boyle[SUP] 3 [/SUP], Kurt Vandegrift[SUP] 5 [/SUP], Meera Surendran Nair[SUP] 3 4 [/SUP], Suresh V Kuchipudi[SUP] 6 4 5 [/SUP], Costas D Maranas[SUP] 7 [/SUP]



Affiliations

Abstract

The association of the receptor binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein with human angiotensin-converting enzyme 2 (hACE2) represents the first required step for cellular entry. SARS-CoV-2 has continued to evolve with the emergence of several novel variants, and amino acid changes in the RBD have been implicated with increased fitness and potential for immune evasion. Reliably predicting the effect of amino acid changes on the ability of the RBD to interact more strongly with the hACE2 can help assess the implications for public health and the potential for spillover and adaptation into other animals. Here, we introduce a two-step framework that first relies on 48 independent 4-ns molecular dynamics (MD) trajectories of RBD-hACE2 variants to collect binding energy terms decomposed into Coulombic, covalent, van der Waals, lipophilic, generalized Born solvation, hydrogen bonding, π-π packing, and self-contact correction terms. The second step implements a neural network to classify and quantitatively predict binding affinity changes using the decomposed energy terms as descriptors. The computational base achieves a validation accuracy of 82.8% for classifying single-amino acid substitution variants of the RBD as worsening or improving binding affinity for hACE2 and a correlation coefficient of 0.73 between predicted and experimentally calculated changes in binding affinities. Both metrics are calculated using a fivefold cross-validation test. Our method thus sets up a framework for screening binding affinity changes caused by unknown single- and multiple-amino acid changes offering a valuable tool to predict host adaptation of SARS-CoV-2 variants toward tighter hACE2 binding.

Keywords: MM-GBSA; SARS-CoV-2; binding affinity; human ACE2; neural network.
 
Back
Top Bottom